๐Ÿ›ก๏ธimmunobiology review

CCL21

Written by the Fiveable Content Team โ€ข Last updated September 2025
Written by the Fiveable Content Team โ€ข Last updated September 2025

Definition

CCL21, also known as secondary lymphoid tissue chemokine (SLC), is a chemokine that plays a vital role in immune responses by guiding lymphocytes to secondary lymphoid organs like lymph nodes. This chemokine is crucial for the organization and function of lymphoid tissues, helping to establish and maintain the immune system's ability to respond to pathogens and other threats effectively.

5 Must Know Facts For Your Next Test

  1. CCL21 is primarily produced by stromal cells in the lymph nodes and other secondary lymphoid organs, providing a crucial signal for lymphocyte migration.
  2. The interaction between CCL21 and its receptor CCR7 is essential for the homing of T cells and dendritic cells to the lymph nodes, facilitating effective immune surveillance.
  3. CCL21 plays a significant role during both steady-state conditions and inflammatory responses by recruiting immune cells to sites where they are needed.
  4. Deficiencies in CCL21 or its signaling pathways can lead to impaired immune responses, affecting the body's ability to combat infections and diseases.
  5. CCL21 not only attracts lymphocytes but also helps maintain the structural integrity of lymphoid tissues, influencing the overall organization of immune cell interactions.

Review Questions

  • How does CCL21 influence the movement of lymphocytes within the immune system?
    • CCL21 directs the movement of lymphocytes by binding to its receptor CCR7 on T cells and dendritic cells, guiding them toward secondary lymphoid organs like lymph nodes. This process is essential for the immune system as it ensures that these immune cells are positioned correctly to encounter antigens and initiate an immune response. Without CCL21, the recruitment of these crucial cells would be impaired, leading to weakened immune surveillance.
  • Discuss the implications of CCL21 deficiency on immune response effectiveness.
    • A deficiency in CCL21 can significantly compromise immune responses by disrupting the proper trafficking of T cells and dendritic cells to lymph nodes. This misdirection means that these important immune players may not reach the sites where they are needed to activate an effective adaptive immune response. As a result, individuals with CCL21 deficiencies could experience heightened susceptibility to infections and an inability to mount proper responses against pathogens or tumor cells.
  • Evaluate how understanding CCL21's role in the immune system could inform therapeutic approaches in immunology.
    • Understanding CCL21's function provides valuable insights into potential therapeutic strategies aimed at enhancing or modulating immune responses. For example, manipulating CCL21 signaling could be beneficial in designing vaccines that improve antigen presentation in lymph nodes or treating conditions where enhanced T cell migration is desired, such as cancer immunotherapy. Additionally, targeting CCL21 pathways may help develop treatments for autoimmune diseases by controlling aberrant immune cell activation and migration.